ZCR 2060
Latest Information Update: 06 Jul 2001
Price :
$50 *
At a glance
- Originator Zeria
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antihistamines; Benzoic acids
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma; Dermatitis
Most Recent Events
- 06 Jul 2001 Discontinued-Preclinical for Allergic rhinitis in Japan (Unknown route)
- 06 Jul 2001 Discontinued-Preclinical for Asthma in Japan (Unknown route)
- 06 Jul 2001 Discontinued-Preclinical for Dermatitis in Japan (Unknown route)